VEGFA and cervical carcinoma: The HPV16/E2 mouse model of cervical carcinoma closely resembles the human counterpart with respect to the progressively intense angiogenic phenotype, with increased bioavailability of vascular endothelial growth factor (VEGF) as one feature [24,25].